GlassScriptPhysician profile
Michael C Topf
NPI 1851711782
$35,681.30
in general payments reported to CMS, 2019-2025
12 companies · $23K in 2025
The $23K reported for 2025 was more than what 98% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $428 · 2020: $75.14 · 2021: $7,985 · 2022: $378 · 2023: $1,408 · 2024: $1,908 · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Travel and Lodging: $3,064 · Food and Beverage: $745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,007.50 |
| Travel and Lodging | $3,063.53 |
| Food and Beverage | $744.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Research & Development, LLC | $12,571.27 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $10,928.41 | 2025 | Libtayo |
| Intuitive Surgical, INC. | $7,351.52 | 2019-2023 | Da Vinci Surgical System |
| Kls-Martin L.P. | $2,419.83 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $1,907.50 | 2024 | |
| Acera Surgical, INC. | $144.56 | 2023 | Restrata Wound Matrix |
| Depuy Synthes Sales INC. | $128.83 | 2019-2022 | |
| Tactile Systems Technology INC | $85.62 | 2019 | |
| Stryker Corporation | $61.68 | 2022-2023 | Vsp System, Vsp Cranial, Na |
| Cook Medical LLC | $44.23 | 2023 | Cook-Swartz |
| Checkpoint Surgical, INC | $21.83 | 2023 | Checkpoint Stimulators |
| Karl Storz Endoscopy-America | $16.02 | 2023 | Image 1 S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Topf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.